Skip to content

Study for the standardized diagnosis and treatment of endometrial carcinoma

Study for the standardized diagnosis and treatment of endometrial carcinoma

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800018705
Enrollment
Unknown
Registered
2018-10-04
Start date
2018-10-10
Completion date
Unknown
Last updated
2018-10-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometrial Cancer

Interventions

Observation group:No irradiation
Group 2:External pelvic irradiation
Group 3:Vaginal cavity irradiation

Sponsors

Shanghai Jiao Tong University Affiliated Sixth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Stage I endometrial carcinoma confirmed by comprehensive stage operation and the pathological type is endometrioid adenocarcinoma; 2. There is at least one moderate risk factor for endometrial cancer: superficial myometrial invasion, G2, age > 60 years old, tumor = 2 cm, lymphatic vascular space invasion.

Exclusion criteria

Exclusion criteria: 1. The pathological type of the patient was a special type of endometrial carcinoma except endometrioid adenocarcinoma; 2. Patients have any high risk factors for endometrial cancer: deep myometrial infiltration, G3, lower uterine segment or cervical gland infiltration; 3. The patient has serious medical complications, such as cardiac and pulmonary insufficiency or severe impairment of liver and kidney functions; 4. The patient had received adjuvant treatment such as radiotherapy or chemotherapy before operation; 5. The patient has been included in other studies and conflicts with this study.

Design outcomes

Primary

MeasureTime frame
5 - year survival rate;Progress - free survival rate;Overall survival rate;

Countries

China

Contacts

Public ContactYincheng Teng

Shanghai Jiao Tong University Affiliated Sixth People's Hospital

teng_yc@126.com+86 18930177643

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026